Genlight Neurotech
PrivateLast Round
Series C
May 12, 2026
Est. Valuation
$1B
Total Funding Raised
$510,000
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Genlight Neurotech is a medical technology company that develops advanced neurosurgical and brain-computer interface solutions, including laser ablation systems and responsive neurostimulation devices for neurological disorders.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging, Medical AI
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Genlight Neurotech Comparables
Compare Genlight Neurotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| 景昱医疗科技（苏州）股份有限公司 | 82% | |
| Beijing PINS Medical Co., Ltd. | 76% | |
| NeuroXess | 71% |
Genlight Neurotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | May 12, 2026 | ||||
| Series B | Jan 16, 2022 | ||||
| Series A | Mar 1, 2021 | ||||
| Pre Seed | Nov 1, 2020 | ||||
| Angel | Jun 1, 2020 |
Key People
Founding team and executive leadership
Genlight Neurotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Yuanjing Capital | Series B |
| Green River | Series A |
| CICC Capital | Series B |
| Zhejiang Haibang Private Equity Fund Management Co., Ltd. | Angel |
| Sherpa Healthcare Partners | Series C |
| Volcanics Venture | Series A |
| Qiming Venture Partners | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 12, 2026
Reached $1B valuation with Series C round.
- Jan 16, 2022
Led by Qiming Venture Partners with participation from CICC Capital, CD Capital, and Yuanjing Capital.
Genlight Neurotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Genlight Neurotech's valuation, stock price, and market status.
Is Genlight Neurotech a public or private company?
Genlight Neurotech is a private company.
What is the current stock price of Genlight Neurotech?
Genlight Neurotech is a private company with no public stock price. No recent secondary market data is available.
How much is Genlight Neurotech worth (valuation)?
Genlight Neurotech's valuation is estimated at $1.0B based on funding round data.
Can I buy Genlight Neurotech stock?
Genlight Neurotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Genlight Neurotech's last funding round?
Genlight Neurotech's most recent funding round was Series C on May 12, 2026.
Who are the main investors in Genlight Neurotech?
Key investors in Genlight Neurotech include Qiming Venture Partners.
Will Genlight Neurotech IPO soon?
No public IPO plans have been announced for Genlight Neurotech.
How can I track Genlight Neurotech secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Genlight Neurotech's secondary market activity and sign up for updates.